Literature DB >> 30069467

Retracted: The Copper Radioisotopes: A Systematic Review with Special Interest to 64Cu.

.   

Abstract

[This retracts the article DOI: 10.1155/2014/786463.].

Entities:  

Year:  2018        PMID: 30069467      PMCID: PMC6057420          DOI: 10.1155/2018/3860745

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


BioMed Research International has retracted the article titled “The Copper Radioisotopes: A Systematic Review with Special Interest to 64Cu” [1]. The article was found to contain a substantial amount of material from the following published articles: Szymański et al. [2], which is cited as reference [4]. Wadas et al. [3], which is cited as reference [3]. Carolyn and Ferdani [4], which is cited as reference [54]. Smith et al. [5], which is cited as reference [34].
  5 in total

Review 1.  The production, separation, and use of 67Cu for radioimmunotherapy: a review.

Authors:  Nicholas A Smith; Delbert L Bowers; David A Ehst
Journal:  Appl Radiat Isot       Date:  2012-07-17       Impact factor: 1.513

Review 2.  Copper chelation chemistry and its role in copper radiopharmaceuticals.

Authors:  T J Wadas; E H Wong; G R Weisman; C J Anderson
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

3.  Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.

Authors:  Carolyn J Anderson; Riccardo Ferdani
Journal:  Cancer Biother Radiopharm       Date:  2009-08       Impact factor: 3.099

Review 4.  Development of copper based drugs, radiopharmaceuticals and medical materials.

Authors:  Paweł Szymański; Tomasz Frączek; Magdalena Markowicz; Elżbieta Mikiciuk-Olasik
Journal:  Biometals       Date:  2012-08-23       Impact factor: 2.949

Review 5.  The copper radioisotopes: a systematic review with special interest to 64Cu.

Authors:  Artor Niccoli Asabella; Giuseppe Lucio Cascini; Corinna Altini; Domenico Paparella; Antonio Notaristefano; Giuseppe Rubini
Journal:  Biomed Res Int       Date:  2014-05-07       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.